CENTRAL ADRENORECEPTORS AND THE CONTROL OF ARTERIAL BLOOD PRESSURE
1974; Wiley; Volume: 1; Issue: 4 Linguagem: Inglês
10.1111/j.1440-1681.1974.tb00557.x
ISSN1440-1681
Autores Tópico(s)Nitric Oxide and Endothelin Effects
ResumoClinical and Experimental Pharmacology and PhysiologyVolume 1, Issue 4 p. 347-360 CENTRAL ADRENORECEPTORS AND THE CONTROL OF ARTERIAL BLOOD PRESSURE M. D. Day, Corresponding Author M. D. Day Pharmacological Laboratories, Department of Pharmacy, University of Aston in BirminghamDr M. D. Day, Pharmacological Laboratories, Department of Pharmacy, University of Aston in Birmingham, Birmingham B4 7ET, U. K.Search for more papers by this authorA. G. Roach, A. G. Roach Pharmacological Laboratories, Department of Pharmacy, University of Aston in BirminghamSearch for more papers by this author M. D. Day, Corresponding Author M. D. Day Pharmacological Laboratories, Department of Pharmacy, University of Aston in BirminghamDr M. D. Day, Pharmacological Laboratories, Department of Pharmacy, University of Aston in Birmingham, Birmingham B4 7ET, U. K.Search for more papers by this authorA. G. Roach, A. G. Roach Pharmacological Laboratories, Department of Pharmacy, University of Aston in BirminghamSearch for more papers by this author First published: August 1974 https://doi.org/10.1111/j.1440-1681.1974.tb00557.xCitations: 30AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Andén, N. E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C. & Svensson, T. (1970) Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sciences, 9, 513–523. 10.1016/0024-3205(70)90207-9 CASPubMedWeb of Science®Google Scholar Andén, N. E., Engel, J. & Rubenson, A. (1972) Mode of action of L-DOPA on central noradrenaline mechanisms. Naunyn-Schmiedeberg's Archives of Pharmacology, 273, 1–10. 10.1007/BF00508076 CASPubMedWeb of Science®Google Scholar Armstrong, J. M. & Boura, A. L. A. (1973) Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat. British Journal of Pharmacology, 47, 850–852. 10.1111/j.1476-5381.1973.tb08214.x CASPubMedWeb of Science®Google Scholar Assaykeen, T. A., Clayton, P. L., Goldfien, A. & Ganong, W. F. (1970) Effect of alpha and beta adrenergic blocking agents on the renin response to hypoglycaemia and epinephrine in dogs. Endocrinology, 87, 1318–1322. 10.1210/endo-87-6-1318 CASPubMedGoogle Scholar Bakke, O. M., Dollery, C. T., Lewis, P. J., Myers, M. G. & Reid, J. L. (1974) Regional brain concentration of propranolol and its hypotensive effect in the conscious rabbit. British Journal of Pharmacology, 51, 148P. CASPubMedWeb of Science®Google Scholar Barrett, A. M., Carter, J., Fitzgerald, J. D., Hull, R. & Le Count, D. (1973) A new type of cardioselective adrenoceptive blocking drug. British Journal of Pharmacology, 48, 340P. CASPubMedWeb of Science®Google Scholar Baum, T., Shropshire, A. T. & Varner, L. L. (1972) Contribution of the central nervous system to the action of several antihypertensive agents (methyldopa, hydralazine and guanethidine). Journal of Pharmacology and Experimental Therapeutics, 182, 135–144. CASPubMedWeb of Science®Google Scholar Bello, C. T., Sevy, R. W. & Harakal, C. (1958) Varying hemodynamic patterns in essential hypertension. American Journal of Medical Science, 250, 24–35. 10.1097/00000441-196507000-00005 PubMedWeb of Science®Google Scholar Benfey, B. G. & Varma, D. R. (1964) Influence of methyldopa on central effects of reserpine. British Journal of Pharmacology, 22, 366–370. 10.1111/j.1476-5381.1964.tb02041.x CASPubMedWeb of Science®Google Scholar Bhargava, K. P., Mishra, N. & Tangri, K. K. (1972) An analysis of central adrenoceptors for control of cardiovascular function. British Journal of Pharmacology, 45, 596–602. 10.1111/j.1476-5381.1972.tb08117.x CASPubMedWeb of Science®Google Scholar Bolme, P. & Fuxe, K. (1971) Pharmacological studies on the hypotensive effects of clonidine. European Journal of Pharmacology, 13, 168–174. 10.1016/0014-2999(71)90147-6 CASPubMedWeb of Science®Google Scholar Bolme, P., Fuxe, K. & Lidbrink, P. (1972) On the function of central catecholamine neurons—their role in cardiovascular and arousal mechanisms. Research Communications in Chemical Pathology and Pharmacology, 4, 657–697. CASPubMedWeb of Science®Google Scholar Bühler, F. R., Laragh, J. H., Baer, L., Vaughan, E. D. & Brunner, H. R. (1972) Propranolol inhibition of renin secretion. New England Journal of Medicine, 287, 1209–1214. 10.1056/NEJM197212142872401 PubMedWeb of Science®Google Scholar Carlsson, A. & Lindqvist, M. (1962) In-vivo decarboxylation of α-methyl DOPA and α-methyl metatyrosine. Acta physiologica scandinavaca, 54, 87–94. 10.1111/j.1748-1716.1962.tb02331.x CASPubMedWeb of Science®Google Scholar Carter, J. K., Mitchell, H. W. & Poyser, R. H. (1974) Comparison of some haemodynamic changes between central and intravenous administration of (±)-propranolol in anaesthetised dogs. British Journal of Pharmacology, 51, 146–147P. Google Scholar Collins, I. S. & King, I. W. (1972) Pindolol (Visken, LB46), a new treatment for hypertension: report of a multicentric open study. Current Therapeutic Research, 14, 185–194. CASPubMedWeb of Science®Google Scholar Conway, E. L. & Lang, W. J. (1974) Cardiovascular responses produced by the injection of isoprenaline and propranolol into the cerebral ventricles of the unanaesthetised dog. Clinical and Experimental Pharmacology and Physiology, 1, 59–64. 10.1111/j.1440-1681.1974.tb00527.x CASPubMedWeb of Science®Google Scholar Crill, W. E. & Reis, D. J. (1968) Distribution of carotid sinus and depressor nerves in cat brain stem. American Journal of Physiology, 214, 269–276. PubMedWeb of Science®Google Scholar Day, M. D. & Rand, M. J. (1963a) A hypothesis for the mode of action of α-methyldopa in relieving hypertension. Journal of Pharmacy and Pharmacology, 15, 221–224. 10.1111/j.2042-7158.1963.tb12778.x CASPubMedWeb of Science®Google Scholar Day, M. D. & Rand, M. J. (1963b) Awakening from reserpine sedation by α-methyldopa. Journal of Pharmacy and Pharmacology, 15, 631–632. 10.1111/j.2042-7158.1963.tb12852.x CASPubMedWeb of Science®Google Scholar Day, M. D. & Rand, M. J. (1964) Some observations on the pharmacology of α-methyldopa. British Journal of Pharmacology and Chemotherapy, 22, 72–86. 10.1111/j.1476-5381.1964.tb01545.x CASPubMedWeb of Science®Google Scholar Day, M. D. & Roach, A. G. (1972) Adrenergic receptors in the central nervous system concerned with cardiovascular control. Journal of Pharmacy and Pharmacology, 24, 148P. CASPubMedWeb of Science®Google Scholar Day, M. D. & Roach, A. G. (1973) β-Adrenergic receptors in the central nervous system of the cat concerned with control of arterial blood pressure and heart rate. Nature New Biology, 242, 30–31. 10.1038/newbio242030a0 CASPubMedWeb of Science®Google Scholar Day, M. D. & Roach, A. G. (1974a) Central α- and β-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats. British Journal of Pharmacology (in press). 10.1111/j.1476-5381.1974.tb10666.x PubMedWeb of Science®Google Scholar Day, M. D. & Roach, A. G. (1974b) Cardiovascular effects of β-adrenoceptor blocking agents after intracerebroventricular administration in conscious normotensive cats. Clinical and Experimental Pharmacology and Physiology, 1, 333–339. 10.1111/j.1440-1681.1974.tb00555.x CASPubMedWeb of Science®Google Scholar Day, M. D., Roach, A. G. & Whiting, R. L. (1973) The mechanism of the antihypertensive action of α-methyldopa in hypertensive rats. European Journal of Pharmacology, 21, 271–280. 10.1016/0014-2999(73)90126-X CASPubMedWeb of Science®Google Scholar Dollery, C. T., Lewis, P. J., Myers, M. G. & Reid, J. L. (1973) Central hypotensive effect of propranolol in the rabbit. British Journal of Pharmacology, 48, 343P. CASPubMedWeb of Science®Google Scholar Dorph, S. & Binder, C. (1969) Evaluation of the hypotensive effect of beta-adrenergic blockade in hypertension. Acta medica scandinavica, 185, 443–448. 10.1111/j.0954-6820.1969.tb07362.x CASPubMedWeb of Science®Google Scholar Eich, R. H., Peters, R. J., Cuddy, R. P., Smulyan, H. & Lyons, R. H. (1962) The hemodynamics in labile hypertension. American Heart Journal, 63, 188–195. 10.1016/0002-8703(62)90195-3 CASPubMedWeb of Science®Google Scholar Eisalo, A., Luomanmaki, K. & Heikkila, J. (1969) Hemodynamic effects of Trasicor, a new beta-adrenergic blocking agent, in hypertensive patients. Acta medica scandinavica, 186, 105–110. 10.1111/j.0954-6820.1969.tb01447.x CASPubMedWeb of Science®Google Scholar Enero, A. M., Langer, S. Z., Rothlin, R. P., Stefano, F. J. E. (1972) Role of the α-adrenoceptor in regulating noradrenaline overflow by nerve stimulation. British Journal of Pharmacology, 44, 672–688. 10.1111/j.1476-5381.1972.tb07306.x CASPubMedWeb of Science®Google Scholar von Euler, U. S. (1946) A specific sympathomimetic ergone in adrenergic nerve fibres (sympathin) and its relations to adrenaline and noradrenaline. Acta physiologica scandinavica, 12, 73–97. 10.1111/j.1748-1716.1946.tb00368.x CASGoogle Scholar Falck, B., Hillarp, N. A., Thieme, G. & Torp, A. (1962) Fluorescence of catecholamines and related compounds condensed with formaldehyde. Journal of Histochemistry and Cytochemistry, 10, 348–354. 10.1177/10.3.348 CASWeb of Science®Google Scholar Farnebo, L. O. & Hamberger, B. (1971) Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta physiologica scandinavaca Supplement, 371, 35–44. 10.1111/j.1748-1716.1971.tb05213.x CASPubMedGoogle Scholar Finkielman, S., Worcel, M. & Agrest, A. (1965) Hemodynamics patterns in essential hypertension. Circulation, 31, 356–368. 10.1161/01.CIR.31.3.356 CASPubMedWeb of Science®Google Scholar Fitzgerald, J. D. (1969) Perspectives in adrenergic beta-receptor blockade. Clinical Pharmacology and Therapeutics, 10, 292–306. 10.1002/cpt1969103292 CASPubMedWeb of Science®Google Scholar Frohlich, E. D. & Bhatia, S. (1972) Hemodynamic effects of propranolol, practolol, and sotalol in hypertensive patients. Clinical Pharmacology and Therapeutics, 13, 138. Web of Science®Google Scholar Frohlich, E. D., Tarazi, R. C., Dustan, H. P. & Page, I. H. (1968) The paradox of beta-adrenergic blockade in hypertension. Circulation, 37, 417–423. 10.1161/01.CIR.37.3.417 CASPubMedWeb of Science®Google Scholar Fulton, R. M., Fulton, E. H. & Green, K. G. (1973) The effect of practolol (‘Eraldin’) in the long-term treatment of severe and moderate hypertension. Clinical Science and Molecular Medicine, 45, 167S–170S. Google Scholar Fuxe, K. (1965) Evidence for the existence of monoamine neurons in the central nervous system. III. The monoamine nerve terminal. Zeitschrift für Zellforschung und mikroskopische Anatomic, 65, 573–596. 10.1007/BF00337069 CASPubMedWeb of Science®Google Scholar Gagnon, D. J. & Melville, K. I. (1966) Further observations on the possible role of noradrenaline in centrally mediated cardiovascular responses. Revue Canadienne de Biologie, 25, 99–105. CASPubMedWeb of Science®Google Scholar Gagnon, D. J. & Melville, K. I. (1967) Centrally mediated cardiovascular responses to isoprenaline. International Journal of Neuropharmacology, 6, 245–251. 10.1016/0028-3908(67)90012-3 CASPubMedGoogle Scholar Garvey, H. L., Ram, N., Woodhouse, B. L. & Booker, W. M. (1972) Centrally mediated antihypertensive effects of propranolol. Federation Proceedings, 31, 923. Google Scholar Granville-Grossman, K. L. & Turner, P. (1966) The effect of propranolol on anxiety. Lancet, i, 788–790. 10.1016/S0140-6736(66)91863-0 CASGoogle Scholar Gysling, E. & Regoli, D. (1973) Oxprenolol: Long-term effects in arterial hypertension. Clinical Pharmacology and Therapeutics, 14, 995–1000. 10.1002/cpt1973146995 CASPubMedWeb of Science®Google Scholar Haggendal, J. (1970) Some further aspects on the release of the adrenergic transmitter. In: New Aspects of Storage and Release Mechanisms of Catecholamines (ed. by H. J. Schumann and G. Kroneberg), pp. 100–111. Springer, Berlin Heidelberg New York . Google Scholar Hamer, J. & Sowton, E. (1965) Cardiac output after beta adrenergic blockade in ischaemic heart disease. British Heart Journal, 27, 892–895. 10.1136/hrt.27.6.892 CASPubMedWeb of Science®Google Scholar Harrison, D. C., Griffin, J. R. & Fiene, T. J. (1965) Effects of β-adrenergic blockade with propranolol in patients with atrial arrhythmias. New England Journal of Medicine, 273, 410–415. 10.1056/NEJM196508192730802 CASPubMedWeb of Science®Google Scholar Heise, A. & Kroneberg, G. (1972) α-Sympathetic receptor stimulation in the brain and hypotensive activity of α-methyldopa. European Journal of Pharmacology. 17, 315–317. 10.1016/0014-2999(72)90180-X CASPubMedWeb of Science®Google Scholar Heise, A. & Kroneberg, G. (1973) Central nervous α-adrenergic receptors and the mode of action of α-methyldopa. Naunyn-Schmiedeberg's Archives of Pharmacology, 279, 285–300. 10.1007/BF00500607 CASPubMedWeb of Science®Google Scholar Henning, M. (1969a) Interaction of DOPA decarboxylase inhibitors with the effect of α-methyldopa on blood pressure and tissue monoamines in rats. Acta pharmacologica scandinavica, 27, 135–148. 10.1111/j.1600-0773.1969.tb00501.x CASPubMedWeb of Science®Google Scholar Henning, M. (1969b) Studies on the mode of action of α-methyldopa. Acta physiologica scandinavica Supplement, 322, 1–37. CASPubMedGoogle Scholar Henning, M. & Rubenson, A. (1971) Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline. Journal of Pharmacy and Pharmacology, 23, 407–411. 10.1111/j.2042-7158.1971.tb08671.x CASPubMedWeb of Science®Google Scholar Henning, M. & van Zwieten, P. A. (1968) Central hypotensive effect of α-methyldopa. Journal of Pharmacy and Pharmacology, 20, 409–417. 10.1111/j.2042-7158.1968.tb09776.x CASPubMedWeb of Science®Google Scholar Hoefke, W. & Kobinger, W. (1966) Pharmakologische Wirkungen des 2-(2,6-dichlorophenylamino)-2-imidazolin-HCl, einer neuen antihypertensiven Substanz. Arzneimittelforschung, 16, 1038–1050. CASPubMedWeb of Science®Google Scholar Holtz, P. (1950) Über die sympathicomimetische Wirksamkeit von Gehirnextrakten. Acta physiologica scandinavica, 20, 354–362. 10.1111/j.1748-1716.1950.tb00712.x CASPubMedWeb of Science®Google Scholar Horowitz, D. & Sjoerdsma, A. (1964) Effects of alpha-methyl-meta-tyrosine intravenously in man. Life Sciences, 3, 41–48. 10.1016/0024-3205(64)90224-3 PubMedWeb of Science®Google Scholar Hoyer, I. & van Zwieten, P. A. (1971) The centrally induced fall in blood pressure after the infusion of amphetamine and related drugs into the vertebral artery of the cat. Journal of Pharmacy and Pharmacology, 23, 892–893. 10.1111/j.2042-7158.1971.tb10214.x CASPubMedWeb of Science®Google Scholar Hoyer, I. & van Zwieten, P. A. (1972) The central hypotensive action of amphetamine, ephedrine, phentermine, chlorphentermine and fenfluramine. Journal of Pharmacy and Pharmacology, 24, 452–458. 10.1111/j.2042-7158.1972.tb09031.x CASPubMedWeb of Science®Google Scholar Jaju, B. P., Tangri, K. K. & Bhargava, K. P. (1966) Central vasomotor effects of α-methyl dopa. Canadian Journal of Physiology and Pharmacology, 44, 687–690. 10.1139/y66-088 CASPubMedWeb of Science®Google Scholar Kelliher, G. J. & Buckley, J. P. (1970) Central hypotensive activity of dl- and d-propranolol. Journal of Pharmaceutical Sciences, 59, 1276–1280. 10.1002/jps.2600590914 CASPubMedWeb of Science®Google Scholar Kobinger, W. & Walland, A. (1972a) Evidence for a central activation of a vagal cardiodepressor reflex by clonidine. European Journal of Pharmacology, 19, 203–209. 10.1016/0014-2999(72)90010-6 CASPubMedWeb of Science®Google Scholar Kobinger, W. & Walland, A. (1972b) Facilitation of vagal reflex bradycardia by an action of clonidine on central α-receptors. European Journal of Pharmacology, 19, 210–217. 10.1016/0014-2999(72)90011-8 CASPubMedWeb of Science®Google Scholar Kobinger, W. & Walland, A. (1973) Modulating effect of central adrenergic neurones on a vagally mediated cardioinhibitory reflex. European Journal of Pharmacology, 22, 344–350. 10.1016/0014-2999(73)90036-8 CASPubMedWeb of Science®Google Scholar Korczyn, A. D. & Goldberg, G. (1974) Inhibition of hypertensive reflexes by propranolol. Research Communications in Chemical Pathology and Pharmacology, 7, 145–152. CASPubMedWeb of Science®Google Scholar Leszkovsky, G. & Tardos, L. (1965) Some effects of propranolol on the central nervous system. Journal of Pharmacy and Pharmacology, 17, 518–519. 10.1111/j.2042-7158.1965.tb07715.x PubMedWeb of Science®Google Scholar Lydtin, H., Kusus, T., Daniel, W., Schierl, W., Ackenheil, M., Kempter, H., Lohmöller, G., Niklas, M. & Walter, I. (1972) Propranolol therapy in essential hypertension. American Heart Journal, 83, 589–595. 10.1016/0002-8703(72)90397-3 CASPubMedWeb of Science®Google Scholar Masuoka, D. & Hansson, E. (1967) Autoradiographic distribution studies of adrenergic blocking agents. II. 14C-propranolol, a β-receptor-type blocker. Acta pharmacologica et toxicologica, 25, 447–455. 10.1111/j.1600-0773.1967.tb00413.x CASPubMedWeb of Science®Google Scholar McCulloch, M. W., Rand, M. J. & Story, D. F. (1972) Inhibition of 3H-noradrenaline release from sympathetic nerves of guinea-pig atria by a presynaptic α-adrenoceptor mechanism. British Journal of Pharmacology, 46, 523–524P. 10.1111/j.1476-5381.1972.tb06856.x Google Scholar Michelakis, A. M. & McAllister, R. G. (1972) The effect of chronic adrenergic receptor blockade on plasma renin activity in man. Journal of Clinical Endocrinology, 34, 386–394. 10.1210/jcem-34-2-386 CASPubMedWeb of Science®Google Scholar Morgan, T. O., Louis, W. J., Dawborn, J. K. & Doyle, A. E. (1972) The use of prindolol (Visken) in the treatment of hypertension. Medical Journal of Australia, 2, 309–312. 10.5694/j.1326-5377.1972.tb47306.x CASPubMedWeb of Science®Google Scholar Muiesan, G., Motolese, M. & Colombi, A. (1973) Hypotensive effect of oxprenolol in mild hypertension: a co-operative controlled study. Clinical Science and Molecular Medicine, 45, 163S–166S. PubMedGoogle Scholar Murmann, W., Almirante, L. & Saccani-Guelfi, M. (1966) Central nervous system effects of four β-adrenergic receptor blocking agents. Journal of Pharmacy and Pharmacology, 18, 317–318. 10.1111/j.2042-7158.1966.tb07878.x CASPubMedWeb of Science®Google Scholar Muscholl, E. (1966) Autonomic nervous system: newer mechanisms of adrenergic blockade. Annual Review of Pharmacology, 6, 107–128. 10.1146/annurev.pa.06.040166.000543 CASPubMedWeb of Science®Google Scholar Muscholl, E. & Maitre, L. (1963) Release by sympathetic stimulation of α-methylnoradrenaline stored in the heart after administration of α-methyldopa. Experientia, 19, 658–659. 10.1007/BF02151307 CASPubMedWeb of Science®Google Scholar Oates, J. A., Gillespie, L., Udenfriend, S. & Sjoerdsma, A. (1960) Decarboxylase inhibition and blood pressure reduction by α-methyl-3,4-dihydroxy-DL-phenylalanine. Science, 131, 1890–1891. 10.1126/science.131.3417.1890 CASPubMedWeb of Science®Google Scholar Owen, D. A. L. & Marsden, C. D. (1965) Effect of adrenergic β-blockade on Parkinsonism tremor. Lancet, ii, 1259–1262. 10.1016/S0140-6736(65)92279-8 CASGoogle Scholar Paterson, J. W. & Dollery, C. T. (1966) Effect of propranolol in mild hypertension. Lancet, ii, 1148–1150. 10.1016/S0140-6736(66)90471-5 Google Scholar Persson, I. & Ulrich, J. (1973) Treatment of hypertension with a new beta-blocking agent, Pindolol (Visken). European Journal of Clinical Pharmacology, 6, 217–219. 10.1007/BF00644734 CASPubMedWeb of Science®Google Scholar Prichard, B. N. C., Boakes, A. J. & Day, G. (1971) Practolol in the treatment of hypertension. Postgraduate Medical Journal, 47, Suppl, 84–92. Google Scholar Prichard, B. N. C. & Gillam, P. M. S. (1964) Use of propranolol (Inderal) in the treatment of hypertension. British Medical Journal, 2, 725–727. 10.1136/bmj.2.5411.725 CASPubMedWeb of Science®Google Scholar Prichard, B. N. C. & Gillam, P. M. S. (1966) Propranolol in hypertension. American Journal of Cardiology, 18, 387–391. 10.1016/0002-9149(66)90059-2 CASPubMedWeb of Science®Google Scholar Prichard, B. N. C. & Gillam, P. M. S. (1969) Treatment of hypertension with propranolol. British Medical Journal, 1, 7–16. 10.1136/bmj.1.5635.7 CASPubMedWeb of Science®Google Scholar Prichard, B. N. C., Shinebourne, E., Fleming, J. & Hamer, J. (1970) Haemodynamic studies in hypertensive patients treated by oral propranolol. British Heart Journal, 32, 236–240. 10.1136/hrt.32.2.236 CASPubMedWeb of Science®Google Scholar Schmitt, H. & Fénard, S. (1971) Effets des substances sympathomimetiques sur les centres vasomoteurs. Archives Internationales de Pharmacodynamie et de Therapie, 190, 229–240. CASPubMedWeb of Science®Google Scholar Schmitt, H., Schmitt, H., Boissier, J. R. & Giudicelli, J. F. (1967) Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S. T. 155, Catapressan). European Journal of Pharmacology, 2, 147–148. 10.1016/0014-2999(67)90041-6 CASPubMedGoogle Scholar Schmitt, H., Schmitt, H. & Fénard, S. (1971) Evidence for an α-sympathomimetic component in the effects of catapressan on vasomotor centres: antagonism by piperoxane. European Journal of Pharmacology, 14, 98–100. 10.1016/0014-2999(71)90130-0 CASPubMedWeb of Science®Google Scholar Schmitt, H., Schmitt, H. & Fénard, S. (1973) Decrease in the sympatho-inhibitory action of clonidine after destruction of the sympatho-inhibitory area. Experientia, 29, 1247–1249. 10.1007/BF01935099 CASPubMedWeb of Science®Google Scholar Share, N. N. (1966) Alpha and beta adrenergic receptors in the medullary vasomotor centre of the cat. Proceedings of the 3rd International Pharmacological Congress, Sao Paulo, p. 116. Google Scholar Sjoerdsma, A., Vendsalu, A. & Engleman, K. (1963) Studies on the metabolism and mechanism of action of methyldopa. Circulation, 28, 492–502. 10.1161/01.CIR.28.4.492 CASPubMedWeb of Science®Google Scholar Sourkes, T. L. (1965) The action of α-methyldopa in the brain. British Medical Bulletin, 21, 66–69. CASPubMedWeb of Science®Google Scholar Srivastava, R. K., Kulshrestha, V. K., Singh, N. & Bhargava, K. P. (1973) Central cardiovascular effects of intracerebroventricular propranolol. European Journal of Pharmacology, 21, 222–229. 10.1016/0014-2999(73)90230-6 CASPubMedWeb of Science®Google Scholar Starke, K. (1971) Influence of α-receptor stimulants on noradrenaline release. Naturwissenschaften, 58, 420. 10.1007/BF00591535 CASPubMedWeb of Science®Google Scholar Starke, K. (1972a) Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn-Schmiedeberg's Archives of Pharmacology, 274, 18–45. 10.1007/BF00501004 CASPubMedWeb of Science®Google Scholar Starke, K. (1972b) Influence of extracellular noradrenaline on the stimulation-evoked secretion of noradrenaline from sympathetic nerves: evidence for an α-receptor mediated feed-back inhibition of noradrenaline release. Naunyn-Schmiedeberg's Archives of Pharmacology, 275, 11–23. 10.1007/BF00505064 CASPubMedWeb of Science®Google Scholar Starke, K. & Montel, H. (1973) Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacology, 12, 1073–1080. 10.1016/0028-3908(73)90051-8 CASPubMedWeb of Science®Google Scholar Stern, S., Hoffman, M. & Braun, K. (1971) Cardiovascular responses to carotid and vertebral artery infusions of propranolol. Cardiovascular Research, 5, 425–430. 10.1093/cvr/5.4.425 CASPubMedWeb of Science®Google Scholar Stone, C. A. & Porter, C. C. (1966) Methyldopa and adrenergic nerve function. Pharmacological Reviews, 18, 569–575. CASPubMedWeb of Science®Google Scholar Stone, C. A., Porter, C. C. & Torchiana, M. L. (1965) Some pharmacologic and physiologic consequences of catecholamine depletion following α-methyl-m-tyrosine. Pharmacologist, 7, 168. Google Scholar Stone, C. A., Porter, C. C., Watson, L. S. & Ross, C. A. (1961) Pharmacology of decarboxylase inhibitors. In Hypertension. The Second Hahnemann Symposium on Hypertensive Disease (ed. by A. N. Brest and J. H. Moyer), pp. 417–423. Lea & Febiger, Philadelphia . Google Scholar Tarazi, R. C. & Dustan, H. P. (1972) Beta adrenergic blockade in hypertension. American Journal of Cardiology, 29, 633–640. 10.1016/0002-9149(72)90164-6 CASPubMedWeb of Science®Google Scholar Tarazi, R. C., Savard, Y., Dustan, H. P. & Bravo, E. L. (1972) Cardioselective beta adrenergic blockade in hypertension. Clinical Pharmacology and Therapeutics, 13, 154. Web of Science®Google Scholar Thorpe, P. (1972) A controlled study of prindolol (Visken) in hypertension. Medical Journal of Australia, 2, 306–309. 10.5694/j.1326-5377.1972.tb47305.x CASPubMedWeb of Science®Google Scholar Tibblin, G. & Åblad, B. (1969) Antihypertensive therapy with alprenolol, a β-adrenergic receptor antagonist. Acta medica scandinavica, 186, 451–457. 10.1111/j.0954-6820.1969.tb01502.x CASPubMedWeb of Science®Google Scholar Toda, N., Matsuda, Y. & Shimamoto, K. (1969) Cardiovascular effects of sympathomimetic amines injected into the cerebral ventricles of rabbits. International Journal of Neuropharmacology, 8, 451–461. 10.1016/0028-3908(69)90061-6 CASPubMedGoogle Scholar Torchiana, M. L. & Stone, C. A. (1964) Effect of methyldopa and related agents on tryamine pressor responses in reserpine-pretreated rats. Pharmacologist, 6, 206. Google Scholar Torchiana, M. L., Wenger, H. C., Stavorski, J., Ludden, C. T. & Stone, C. A. (1966) Effect of methyldopa and related agents on tyramine pressor responses in reserpinized rats and dogs. Journal of Pharmacology and Experimental Therapeutics, 151, 242–252. CASPubMedWeb of Science®Google Scholar Udenfriend, S. & Zaltman-Nirenberg, P. (1963) On the mechanism of the norepinephrine release produced by α-methyl-meta-tyrosine. Journal of Pharmacology and Experimental Therapeutics, 138, 194–199. PubMedWeb of Science®Google Scholar Ulrych, M., Frohlich, E. D., Dustan, H. P. & Page, I. H. (1968) Immediate haemodynamic effects of beta adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation, 37, 411–416. 10.1161/01.CIR.37.3.411 CASPubMedWeb of Science®Google Scholar Vizi, E. S., Somogyi, G. T., Hadhazy, P. & Knoll, J. (1973) Effect of duration and frequency of stimulation on presynaptic inhibition by α-adrenoreceptor stimulation of the adrenergic transmission. Naunyn-Schmiedeberg's Archives of Pharmacology, 280, 79–91. 10.1007/BF00505357 CASPubMedWeb of Science®Google Scholar Vogt, M. (1954) The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. Journal of Physiology, 123, 451–481. 10.1113/jphysiol.1954.sp005064 CASPubMedWeb of Science®Google Scholar Vollmer, R. R., Cavero, I., Ertel, R. J., Solomon, T. A. & Buckley, J. P. (1974) Role of the central autonomic nervous system in the hypotension and bradycardia induced by (—)-Δ9-trans-tetrahydrocannabinol. Journal of Pharmacy and Pharmacology, 26, 186–192. 10.1111/j.2042-7158.1974.tb09252.x CASPubMedWeb of Science®Google Scholar Waal, H. J. (1966) Hypotensive action of propranolol. Clinical Pharmacology and Therapeutics, 7, 588–598. 10.1002/cpt196675588 CASPubMedWeb of Science®Google Scholar Weber, M. A., Thornell, I. R. & Stokes, G. S. (1974) Effects of beta adrenergic blocking agents on the plasma renin activity in the conscious rabbit. Journal of Pharmacology and Experimental Therapeutics, 188, 234–240. CASPubMedWeb of Science®Google Scholar Widinsky, J., Fejfarova, M. H. & Fejfar, Z. (1957) Changes of cardiac output in hypertensive disease. Cardiologia, 31, 381–389. 10.1159/000165747 PubMedGoogle Scholar Winer, N. (1974) Hypotensive action of propranolol (P) dissociated from its antirenin effect. Clinical Research, 22, 15A. Google Scholar Yamori, Y., de Jong, W., Yamabe, H., Lovenberg, W. & Sjoerdsma, A. (1972) Effects of L-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive rats. Journal of Pharmacy and Pharmacology, 24, 690–695. 10.1111/j.2042-7158.1972.tb09091.x CASPubMedWeb of Science®Google Scholar Zacharias, F. J. & Cowen, K. J. (1970) Controlled trial of propranolol in hypertension. British Medical Journal, 1, 471–474. 10.1136/bmj.1.5694.471 CASPubMedWeb of Science®Google Scholar Zacharias, F. J., Cowen, K. J., Prestt, J., Vickers, J. & Wall, B. G. (1972) Propranolol in hypertension: a study of long term therapy. American Heart Journal, 83, 755–761. 10.1016/0002-8703(72)90206-2 CASPubMedWeb of Science®Google Scholar van Zwieten, P. A. (1973) The central action of antihypertensive drugs, mediated via central α-receptors. Journal of Pharmacy and Pharmacology, 25, 89–95. 10.1111/j.2042-7158.1973.tb10599.x PubMedWeb of Science®Google Scholar Citing Literature Volume1, Issue4August 1974Pages 347-360 ReferencesRelatedInformation
Referência(s)